Skip to main content

Table 1 Exosomal and autophagic proteins as potential biomarkers

From: Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells

Cancer type Exosomal proteins as biomarker Autophagic proteins as biomarker
Bladder α6-integrin, Basigin, TACSTD2, Mucin4, EDIL-3, EPS8L2, MUC-1 [169] NR
Breast Survivin, Survivin-2B, CEA, Tumor antigen15-3 [170] LC3β [171], LC3α [172], ULK-1 [173], Beclin-1 [174], FIP200 [175]
Cervical ATF1, RAS [176] NR
Colorectal CEA [110] Beclin1, LC3β [174]
Gastric NR ULK1, Beclin 1, ATG3, ATG10 [161]
Melanoma CD63, Caveolin1, TYRP2, VLA-4, HSP70 [110] LC3β [178]
lung EpCAM, EGFR, CEA, LRG-1 [179] LC3β [180], Beclin-1 [174]
Ovarian MAGE3/6, Claudin-4, L1CAM, TGFβ1, CD24, ADAM10, EMMPRIN [181] NR
Pancreatic GPC1, MIF [182] NR
Prostate Survivin, PTEN, Transmembranes, Protease, ITGB1, Serine2-ETS, β-catenin, PSA, PCA3, PSMA, ITGA3 [183] NR
  1. NR means not recorded